InvestorsObserver is giving GW Pharmaceuticals PLC- ADR (GWPH) an Analyst Rating Rank of 72, meaning GWPH is ranked higher by analysts than 72% of stocks. The average projection by analysts for GWPH is $182.538 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
Investors Observer combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With GW Pharmaceuticals PLC- ADR Stock Today?
GW Pharmaceuticals PLC- ADR (GWPH) stock is lower by -18.05% while the S&P 500 has risen 0.03% as of 2:13 PM on Friday, Aug 7. GWPH is lower by -$23.85 from the previous closing price of $132.10 on volume of 1,507,038 shares. Over the past year the S&P 500 is higher by 14.02% while GWPH is lower by -36.14%. GWPH earned $1.03 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 106.37.
